tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ORIC Stock Latest News

Oric Pharmaceuticals price target raised to $25 from $23 at H.C. Wainwright
The FlyOric Pharmaceuticals price target raised to $25 from $23 at H.C. Wainwright
11d ago
ORIC
Oric Pharmaceuticals price target raised to $17 from $16 at Citi
PremiumThe Fly
Oric Pharmaceuticals price target raised to $17 from $16 at Citi
11d ago
ORIC
Oric Pharmaceuticals Launches New 2026 ATM Share Program
PremiumCompany Announcements
Oric Pharmaceuticals Launches New 2026 ATM Share Program
12d ago
8K
ORIC
Oric Pharmaceuticals reports Q4 EPS (30c), consensus (37c)
PremiumThe Fly
Oric Pharmaceuticals reports Q4 EPS (30c), consensus (37c)
12d ago
ORIC
Oric Pharmaceuticals expects cash to fund operations into 2H 2028
PremiumThe Fly
Oric Pharmaceuticals expects cash to fund operations into 2H 2028
12d ago
ORIC
Oric Pharmaceuticals announces upcoming milestones
PremiumThe FlyOric Pharmaceuticals announces upcoming milestones
12d ago
ORIC
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
Premium
Stock Analysis & Ideas
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
2M ago
OLMA
ORIC
ORIC Pharmaceuticals: Dense Near‑Term Clinical Catalysts and Encouraging Efficacy Data Underpin Reiterated Buy Rating
Premium
Ratings
ORIC Pharmaceuticals: Dense Near‑Term Clinical Catalysts and Encouraging Efficacy Data Underpin Reiterated Buy Rating
2M ago
ORIC
Oric Pharmaceuticals provides operational highlights for 2025
PremiumThe Fly
Oric Pharmaceuticals provides operational highlights for 2025
2M ago
ORIC
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
PremiumMarket News
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
2M ago
OLMA
ORIC
Oric Pharmaceuticals initiated with an Overweight at Piper Sandler
PremiumThe Fly
Oric Pharmaceuticals initiated with an Overweight at Piper Sandler
2M ago
ORIC
Oric Pharmaceuticals Highlights Promising Enozertinib Trial Results
PremiumCompany Announcements
Oric Pharmaceuticals Highlights Promising Enozertinib Trial Results
3M ago
8K
ORIC
Oric Pharmaceuticals price target raised to $25 from $19 at Wells Fargo
PremiumThe FlyOric Pharmaceuticals price target raised to $25 from $19 at Wells Fargo
3M ago
ORIC
Buy Rating for Oric Pharmaceuticals: Enozertinib’s Promising Efficacy and Strategic Value
Premium
Ratings
Buy Rating for Oric Pharmaceuticals: Enozertinib’s Promising Efficacy and Strategic Value
3M ago
ORIC
Oric Pharmaceuticals presents data from Phase 1b trial of enozertinib
Premium
The Fly
Oric Pharmaceuticals presents data from Phase 1b trial of enozertinib
3M ago
ORIC
Promising Clinical Data and Market Potential Drive Buy Rating for Oric Pharmaceuticals’ Enozertinib
PremiumRatings
Promising Clinical Data and Market Potential Drive Buy Rating for Oric Pharmaceuticals’ Enozertinib
3M ago
ORIC
Oric Pharmaceuticals presents data from enozertinib trial at ESMO Asia
PremiumThe Fly
Oric Pharmaceuticals presents data from enozertinib trial at ESMO Asia
3M ago
ORIC
Oric Pharmaceuticals presents data from enozertinib trial at ESMO Asia
PremiumThe Fly
Oric Pharmaceuticals presents data from enozertinib trial at ESMO Asia
3M ago
ORIC
Oric Pharmaceuticals initiated as Early Stage Biotech at Goldman Sachs
PremiumThe Fly
Oric Pharmaceuticals initiated as Early Stage Biotech at Goldman Sachs
3M ago
ORIC
Buy Rating for Oric Pharmaceuticals: Promising Developments and Enozertinib’s Potential in NSCLC Treatment
PremiumRatingsBuy Rating for Oric Pharmaceuticals: Promising Developments and Enozertinib’s Potential in NSCLC Treatment
3M ago
ORIC
Oric Pharmaceuticals initiated with an Outperform at Evercore ISI
Premium
The Fly
Oric Pharmaceuticals initiated with an Outperform at Evercore ISI
4M ago
ORIC
Promising Potential of Oric Pharmaceuticals’ ORIC-944 in Prostate Cancer Market Drives Buy Rating
Premium
Ratings
Promising Potential of Oric Pharmaceuticals’ ORIC-944 in Prostate Cancer Market Drives Buy Rating
4M ago
ORIC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >